Gainline Financial Partners LLC acquired a new position in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 1,758 shares of the semiconductor company’s stock, valued at approximately $762,000. Lam Research makes up about 0.7% of Gainline Financial Partners LLC’s portfolio, making the stock its 25th largest position.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp raised its stake in Lam Research by 0.4% during the third quarter. State Street Corp now owns 59,817,352 shares of the semiconductor company’s stock valued at $8,024,684,000 after purchasing an additional 265,805 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Lam Research by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 33,747,368 shares of the semiconductor company’s stock worth $5,764,117,000 after buying an additional 126,613 shares in the last quarter. Invesco Ltd. grew its stake in shares of Lam Research by 7.7% in the 4th quarter. Invesco Ltd. now owns 22,821,354 shares of the semiconductor company’s stock worth $3,906,559,000 after buying an additional 1,638,406 shares in the last quarter. Norges Bank purchased a new position in shares of Lam Research in the 4th quarter worth $3,645,427,000. Finally, Price T Rowe Associates Inc. MD increased its holdings in shares of Lam Research by 352.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock worth $2,344,347,000 after buying an additional 10,666,540 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
LRCX has been the topic of several recent research reports. Rothschild & Co Redburn upped their target price on shares of Lam Research from $305.00 to $420.00 and gave the company a “buy” rating in a research report on Wednesday, June 17th. Weiss Ratings upgraded Lam Research from a “buy (b-)” rating to a “buy (b)” rating in a research report on Friday, August 21st. TD Cowen reissued a “buy” rating and set a $400.00 price objective (up from $340.00) on shares of Lam Research in a research note on Thursday, July 9th. Wells Fargo & Company restated an “overweight” rating and set a $350.00 price objective (down from $450.00) on shares of Lam Research in a research report on Thursday, July 30th. Finally, Stifel Nicolaus raised their price objective on Lam Research from $325.00 to $425.00 and gave the company a “buy” rating in a research note on Friday, July 10th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $358.97.
Insider Transactions at Lam Research
In other news, Director Abhijit Talwalkar sold 18,282 shares of the stock in a transaction that occurred on Monday, July 13th. The stock was sold at an average price of $335.00, for a total value of $6,124,470.00. Following the sale, the director directly owned 87,142 shares in the company, valued at approximately $29,192,570. This represents a 17.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the firm’s stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the sale, the director directly owned 199,205 shares of the company’s stock, valued at $69,881,114. This represents a 21.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 77,782 shares of company stock worth $26,755,370. 0.31% of the stock is currently owned by company insiders.
More Lam Research News
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Lam Research’s record June-quarter results and outlook remain key catalysts. Revenue reached $6.72 billion, up 30% year over year, while adjusted earnings exceeded analysts’ expectations. Management guided for approximately $8.10 billion in September-quarter revenue, reinforcing confidence in continued AI- and advanced-chip-related demand. Lam Research gains as investors build on strong guidance and recent shareholder-friendly updates
- Positive Sentiment: The company broke ground on a new Oregon research laboratory and plans to invest more than $3 billion in its global lab network over five years. The investment is intended to support semiconductor research tied to artificial intelligence and next-generation chip production. Lam Research Oregon laboratory announcement
- Positive Sentiment: Lam Research raised its quarterly dividend by approximately 27% to $0.33 per share, improving the stock’s shareholder-return profile after its record quarter. Lam Research dividend increase
- Positive Sentiment: Options activity and bullish institutional positioning may be adding to momentum. More than 1,600 institutions reportedly increased their holdings in the latest quarter, while recent analyst targets—including several between $400 and $500—remain above the current trading range. Lam Research options market article
- Neutral Sentiment: The dividend increase has attracted attention as investors seek income and quality amid geopolitical and inflation concerns, although broader market volatility could continue to affect semiconductor stocks. Stocks with dividend hikes article
- Negative Sentiment: Insiders have reported only sales—not purchases—in the past six months, including transactions by CEO Timothy Archer and other executives. That activity may raise concerns about valuation or profit-taking.
- Negative Sentiment: After substantial long-term gains, some commentary argues that LRCX is fully valued, with elevated valuation metrics leaving less room for disappointment-free execution. UBS also recently lowered its price target to $425, despite remaining above the current share price. UBS lowers Lam Research price target
Lam Research Price Performance
Lam Research stock opened at $307.65 on Friday. Lam Research Corporation has a 12-month low of $100.68 and a 12-month high of $438.50. The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30. The firm has a 50-day moving average price of $321.34 and a 200-day moving average price of $291.39. The firm has a market capitalization of $384.97 billion, a PE ratio of 53.41, a price-to-earnings-growth ratio of 1.16 and a beta of 1.85.
Lam Research (NASDAQ:LRCX – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The company had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. During the same period in the prior year, the firm posted $1.33 EPS. The firm’s revenue was up 30.0% compared to the same quarter last year. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, equities research analysts forecast that Lam Research Corporation will post 9.33 EPS for the current year.
Lam Research Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd will be paid a dividend of $0.33 per share. This is a positive change from Lam Research’s previous quarterly dividend of $0.26. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Wednesday, September 23rd. Lam Research’s payout ratio is currently 18.06%.
Lam Research Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories
- Five stocks we like better than Lam Research
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
